Preclinical safety studies of human embryonic stem cell‐derived retinal pigment epithelial cells for the treatment of age‐related macular degeneration

As pluripotent stem cell (PSC)‐based reparative cell therapies are reaching the bedside, there is a growing need for the standardization of studies concerning safety of the derived products. Clinical trials using these promising strategies are in development, and treatment for age‐related macular de...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrus‐Reurer, Sandra, Kumar, Pankaj, Padrell Sánchez, Sara, Aronsson, Monica, André, Helder, Bartuma, Hammurabi, Plaza Reyes, Alvaro, Nandrot, Emeline F., Kvanta, Anders, Lanner, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Manufacturing for Regenerative Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381808/
https://www.ncbi.nlm.nih.gov/pubmed/32319201
http://dx.doi.org/10.1002/sctm.19-0396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381808/
https://www.ncbi.nlm.nih.gov/pubmed/32319201
http://dx.doi.org/10.1002/sctm.19-0396

Ejemplares similares